149 related articles for article (PubMed ID: 2659742)
1. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides.
Yin JZ; Bell MK; Thorbecke GJ
J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742
[TBL] [Abstract][Full Text] [Related]
2. The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.
Kong AS; Morse SI
J Immunol; 1976 Apr; 116(4):989-93. PubMed ID: 3610
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
Shimauchi H
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
[TBL] [Abstract][Full Text] [Related]
4. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
[TBL] [Abstract][Full Text] [Related]
5. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):52-64. PubMed ID: 1446
[TBL] [Abstract][Full Text] [Related]
7. Immunosupression of the primary and secondary immune response by an IgM plasmacytoma (TEPC-183).
Havas HF; Schiffman GD; Fenton M; Goodis A; Braverman S
Immunology; 1979 Feb; 36(2):191-7. PubMed ID: 35463
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man.
Kehrl JH; Fauci AS
Bull Eur Physiopathol Respir; 1983; 19(2):227-34. PubMed ID: 6347283
[TBL] [Abstract][Full Text] [Related]
9. Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody.
Lees A; Morris SC; Thyphronitis G; Holmes JM; Inman JK; Finkelman FD
J Immunol; 1990 Dec; 145(11):3594-600. PubMed ID: 2246504
[TBL] [Abstract][Full Text] [Related]
10. The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice.
Smith AM
J Immunol; 1976 Feb; 116(2):469-74. PubMed ID: 2635
[TBL] [Abstract][Full Text] [Related]
11. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
Friedman H
Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides.
Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
Havas HF; Schiffman G
Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
[TBL] [Abstract][Full Text] [Related]
14. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
Buchanan RM; Arulanandam BP; Metzger DW
J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
[TBL] [Abstract][Full Text] [Related]
15. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.
Braley-Mullen H
J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609
[TBL] [Abstract][Full Text] [Related]
16. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
17. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
18. Prevention by a platelet-derived factor (platelet factor 4) of induction of low dose tolerance to pneumococcal polysaccharides.
Yin JZ; Zucker MB; Clarke D; Bell MK; Thorbecke GJ
Cell Immunol; 1988 Sep; 115(2):221-7. PubMed ID: 3409328
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. IV. The roles of antigen and adjuvant for induction of primary and secondary antibody responses and for development of immunological memory to bovine serum albumin.
Nakashima I; Kato N
Jpn J Microbiol; 1975 Aug; 19(4):277-85. PubMed ID: 1104933
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
